Macrophages in renal disease

Journal of the American Society of Nephrology

Volumn 22, Issue 1, 2011, Pages 21-27

  Wang, Yiping ^a   Harris, David C H ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIINFLAMMATORY AGENT; ANTISENSE OLIGONUCLEOTIDE; C FMS ANTIBODY; CD11B ANTIGEN; CD18 ANTIBODY; CHEMOKINE RECEPTOR CX3CR1 ANTIBODY; DNA VACCINE; ED7 ANTIBODY; I KAPPA B; INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 4; LIPOSOMAL CLODRONATE; MONOCYTE CHEMOATTRACTANT PROTEIN 1 VACCINE; MONOCYTE CHEMOTACTIC PROTEIN 1 ANTIBODY; RANTES VACCINE; UNCLASSIFIED DRUG;

ALLERGIC GLOMERULONEPHRITIS; ANTIINFLAMMATORY ACTIVITY; CD4+ CD25+ T LYMPHOCYTE; CYTOKINE PRODUCTION; EXPERIMENTAL MODEL; KIDNEY DISEASE; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; RENAL PROTECTION; SHORT SURVEY;

EID: 78651398351     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2010030269     Document Type: Short Survey

References (66)

1. Lan HY, Paterson DJ, Atkins RC: Initiation and evolution of interstitial leukocytic infiltration in experimental glomerulonephritis. Kidney Int 40: 425-433, 1991
2. Ferrario F, Castiglione A, Colasanti G, Barbiano di Belgioioso G, Bertoli S, D'Amico G: The detection of monocytes in human glomerulonephritis. Kidney Int 28: 513-519, 1985
3. Bohle A, Wehrmann M, Bogenschutz O, Batz C, Vogl W, Schmitt H, Muller CA, Muller GA: The long-term prognosis of the primary glomerulonephritides. A morphological and clinical analysis of 1747 cases. Pathol Res Pract 188: 908-924, 1992
4. Rodriguez-Iturbe B, Pons H, Herrera-Acosta J, Johnson RJ: Role of immunocompetent cells in nonimmune renal diseases. Kidney Int 59: 1626-1640, 2001
5. Cook HT, Smith J, Salmon JA, Cattell V: Functional characteristics of macrophages in glomerulonephritis in the rat. O2- generation, MHC class II expression, and eicosanoid synthesis. Am J Pathol 134: 431-437, 1989
6. Boyce NW, Tipping PG, Holdsworth SR: Glomerular macrophages produce reactive oxygen species in experimental glomerulonephritis. Kidney Int 35: 778-782, 1989
7. Cattell V, Largen P, de Heer E, Cook T: Glomeruli synthesize nitrite in active Heymann nephritis; the source is infiltrating macrophages. Kidney Int 40: 847-851, 1991
8. Tipping PG, Lowe MG, Holdsworth SR: Glomerular interleukin 1 production is dependent on macrophage infiltration in anti-GBM glomerulonephritis. Kidney Int 39: 103-110, 1991
9. Matsumoto K, Dowling J, Atkins RC: Production of interleukin 1 in glomerular cell cultures from patients with rapidly progressive crescentic glomerulonephritis. Am J Nephrol 8: 463-470, 1988
10. Matsumoto K: Production of interleukin-1 by glomerular macrophages in nephrotoxic serum nephritis. Am J Nephrol 10: 502-506, 1990
11. Tipping PG, Leong TW, Holdsworth SR: Tumor necrosis factor production by glomerular macrophages in anti-glomerular basement membrane glomerulonephritis in rabbits. Lab Invest 65: 272-279, 1991
12. Boswell JM, Yui MA, Burt DW, Kelley VE: Increased tumor necrosis factor and IL-1 beta gene expression in the kidneys of mice with lupus nephritis. J Immunol 141: 3050-3054, 1988
13. Noronha IL, Kruger C, Andrassy K, Ritz E, Waldherr R: In situ production of TNF-alpha, IL-1 beta and IL-2R in ANCA-positive glomerulonephritis. Kidney Int 43: 682-692, 1993
14. Tan TK, Zheng G, Hsu TT, Wang Y, Lee VW, Tian X, Wang Y, Cao Q, Wang Y, Harris DC: Macrophage matrix metalloproteinase-9 mediates epithelial-mesenchymal transition in vitro in murine renal tubular cells. Am J Pathol 176: 1256-1270, 2010
15. Nikolic-Paterson DJ, Lan LH, Atkins RC: Macrophages in immune renal injury. In: Immunologic Renal Disease, 2nd Ed., edited by Neilson EG, Couser WG, Philadelphia, Lippincott, Williams & Wilkins, 2001, pp 609-632
16. Diamond JR, Pesek-Diamond I: Sublethal X-irradiation during acute puromycin nephrosis prevents late renal injury: Role of macrophages. Am J Physiol 260: F779-F786, 1991
17. Holdsworth SR, Neale TJ, Wilson CB: Abrogation of macrophage-dependent injury in experimental glomerulonephritis in the rabbit. Use of an antimacrophage serum. J Clin Invest 68: 686-698, 1981
18. Hara M, Batsford SR, Mihatsch MJ, Bitter-Suermann D, Vogt A: Complement and monocytes are essential for provoking glomerular injury in passive Heymann nephritis in rats. Terminal complement components are not the sole mediators of proteinuria. Lab Invest 65: 168-179, 1991
19. Tang WW, Qi M, Warren JS: Monocyte chemoattractant protein 1 mediates glomerular macrophage infiltration in anti-GBM Ab GN. Kidney Int 50: 665-671, 1996
20. Ikezumi Y, Hurst LA, Masaki T, Atkins RC, Nikolic-Paterson DJ: Adoptive transfer studies demonstrate that macrophages can induce proteinuria and mesangial cell proliferation. Kidney Int 63: 83-95, 2003
21. Wang Y, Wang Y, Cao Q, Zheng G, Lee VW, Zheng D, Li X, Tan TK, Harris DC: By homing to the kidney, activated macrophages potently exacerbate renal injury. Am J Pathol 172: 1491-1499, 2008
22. Wang Y, Mahajan D, Tay YC, Bao S, Spicer T, Kairaitis L, Rangan GK, Harris DC: Partial depletion of macrophages by ED7 reduces renal injury in Adriamycin nephropathy. Nephrology (Carlton) 10: 470-477, 2005
23. Le Meur Y, Tesch GH, Hill PA, Mu W, Foti R, Nikolic-Paterson DJ, Atkins RC: Macrophage accumulation at a site of renal inflammation is dependent on the M-CSF/c-fms pathway. J Leukoc Biol 72: 530-537, 2002
24. Lim AK, Ma FY, Nikolic-Paterson DJ, Thomas MC, Hurst LA, Tesch GH: Antibody blockade of c-fms suppresses the progression of inflammation and injury in early diabetic nephropathy in obese db/db mice. Diabetologia 52: 1669-1679, 2009
25. Kitamoto K, Machida Y, Uchida J, Izumi Y, Shiota M, Nakao T, Iwao H, Yukimura T, Nakatani T, Miura K: Effects of liposome clodronate on renal leukocyte populations and renal fibrosis in murine obstructive nephropathy. J Pharmacol Sci 111: 285-292, 2009
26. Duffield JS, Tipping PG, Kipari T, Cailhier JF, Clay S, Lang R, Bonventre JV, Hughes J: Conditional ablation of macrophages halts progression of crescentic glomerulonephritis. Am J Pathol 167: 1207-1219, 2005
27. Feng L, Chen S, Garcia GE, Xia Y, Siani MA, Botti P, Wilson CB, Harrison JK, Bacon KB: Prevention of crescentic glomerulonephritis by immunoneutralization of the fractalkine receptor CX3CR1 rapid communication. Kidney Int 56: 612-620, 1999
28. Lloyd CM, Dorf ME, Proudfoot A, Salant DJ, Gutierrez-Ramos JC: Role of MCP-1 and RANTES in inflammation and progression to fibrosis during murine crescentic nephritis. J Leukoc Biol 62: 676-680, 1997
29. Wada T, Yokoyama H, Furuichi K, Kobayashi KI, Harada K, Naruto M, Su SB, Akiyama M, Mukaida N, Matsushima K: Intervention of crescentic glomerulonephritis by antibodies to monocyte chemotactic and activating factor (MCAF/MCP-1). FASEB J 10: 1418-1425, 1996
30. Wenzel U, Schneider A, Valente AJ, Abboud HE, Thaiss F, Helmchen UM, Stahl RA: Monocyte chemoattractant protein-1 mediates monocyte/macrophage influx in antithymocyte antibody-induced glomerulonephritis. Kidney Int 51: 770-776, 1997
31. Wu H, Wang Y, Tay YC, Zheng G, Zhang C, Alexander SI, Harris DC: DNA vaccination with naked DNA encoding MCP-1 and RANTES protects against renal injury in adriamycin nephropathy. Kidney Int 67: 2178-2186, 2005
32. Zheng G, Wang Y, Xiang SH, Tay YC, Wu H, Watson D, Coombes J, Rangan GK, Alexander SI, Harris DC: DNA vaccination with CCL2 DNA modified by the addition of an adjuvant epitope protects against "nonimmune" toxic renal injury. J Am Soc Nephrol 17: 465-474, 2006
33. Fujinaka H, Yamamoto T, Takeya M, Feng L, Kawasaki K, Yaoita E, Kondo D, Wilson CB, Uchiyama M, Kihara I: Suppression of antiglomerular basement membrane nephritis by administration of anti-monocyte chemoattractant protein-1 antibody in WKY rats. J Am Soc Nephrol 8: 1174-1178, 1997
34. Panzer U, Thaiss F, Zahner G, Barth P, Reszka M, Reinking RR, Wolf G, Helmchen U, Stahl RA: Monocyte chemoattractant protein-1 and osteopontin differentially regulate monocytes recruitment in experimental glomerulonephritis. Kidney Int 59: 1762-1769, 2001
35. Lloyd CM, Minto AW, Dorf ME, Proudfoot A, Wells TN, Salant DJ, Gutierrez-Ramos JC: RANTES and monocyte chemoattractant protein-1 (MCP-1) play an important role in the inflammatory phase of crescentic nephritis, but only MCP-1 is involved in crescent formation and interstitial fibrosis. J Exp Med 185: 1371-1380, 1997
36. Anders HJ, Frink M, Linde Y, Banas B, Wornle M, Cohen CD, Vielhauer V, Nelson PJ, Grone HJ, Schlondorff D: CC chemokine ligand 5/RANTES chemokine antagonists aggravate glomerulonephritis despite reduction of glomerular leukocyte infiltration. J Immunol 170: 5658-5666, 2003
37. Kawasaki K, Yaoita E, Yamamoto T, Tamatani T, Miyasaka M, Kihara I: Antibodies against intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 prevent glomerular injury in rat experimental crescentic glomerulonephritis. J Immunol 150: 1074-1083, 1993
38. Wu X, Tiwari AK, Issekutz TB, Lefkowith JB: Differing roles of CD18 and VLA-4 in leukocyte migration/activation during anti-GBM nephritis. Kidney Int 50: 462-472, 1996
39. Tomita N, Morishita R, Lan HY, Yamamoto K, Hashizume M, Notake M, Toyosawa K, Fujitani B, Mu W, Nikolic-Paterson DJ, Atkins RC, Kaneda Y, Higaki J, Ogihara T: In vivo administration of a nuclear transcription factor-kappaB decoy suppresses experimental crescentic glomerulonephritis. J Am Soc Nephrol 11: 1244-1252, 2000
40. Kiew LV, Munavvar AS, Law CH, Azizan AN, Nazarina AR, Sidik K, Johns EJ: Effect of antisense oligodeoxynucleotides for ICAM-1 on renal ischaemia-reperfusion injury in the anaesthetised rat. J Physiol 557: 981-989, 2004
41. Clauss S, Gross O, Kulkarni O, Avila-Ferrufino A, Radomska E, Segerer S, Eulberg D, Klussmann S, Anders HJ: Ccl2/Mcp-1 blockade reduces glomerular and interstitial macrophages but does not ameliorate renal pathology in collagen4A3-deficient mice with autosomal recessive Alport nephropathy. J Pathol 218: 40-47, 2009
42. Yamagishi H, Yokoo T, Imasawa T, Mitarai T, Kawamura T, Utsunomiya Y: Genetically modified bone marrow-derived vehicle cells site specifically deliver an anti-inflammatory cytokine to inflamed interstitium of obstructive nephropathy. J Immunol 166: 609-616, 2001
43. Yokoo T, Ohashi T, Utsunomiya Y, Kojima H, Imasawa T, Kogure T, Hisada Y, Okabe M, Eto Y, Kawamura T, Hosoya T: Prophylaxis of antibody-induced acute glomerulonephritis with genetically modified bone marrow-derived vehicle cells. Hum Gene Ther 10: 2673-2678, 1999
44. Wilson HM, Stewart KN, Brown PA, Anegon I, Chettibi S, Rees AJ, Kluth DC: Bone-marrow-derived macrophages genetically modified to produce IL-10 reduce injury in experimental glomerulonephritis. Mol Ther 6: 710-717, 2002
45. Kluth DC, Ainslie CV, Pearce WP, Finlay S, Clarke D, Anegon I, Rees AJ: Macrophages transfected with adenovirus to express IL-4 reduce inflammation in experimental glomerulonephritis. J Immunol 166: 4728-4736, 2001
46. Kluth DC, Erwig LP, Rees AJ: Multiple facets of macrophages in renal injury. Kidney Int 66: 542-557, 2004
47. Wilson HM, Chettibi S, Jobin C, Walbaum D, Rees AJ, Kluth DC: Inhibition of macrophage nuclear factor-kappaB leads to a dominant anti-inflammatory phenotype that attenuates glomerular inflammation in vivo. Am J Pathol 167: 27-37, 2005
48. Herbert DR, Holscher C, Mohrs M, Arendse B, Schwegmann A, Radwanska M, Leeto M, Kirsch R, Hall P, Mossmann H, Claussen B, Forster I, Brombacher F: Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology. Immunity 20: 623-635, 2004 (Pubitemid 38659504)
49. Pull SL, Doherty JM, Mills JC, Gordon JI, Stappenbeck TS: Activated macrophages are an adaptive element of the colonic epithelial progenitor niche necessary for regenerative responses to injury. Proc Natl Acad Sci U S A 102: 99-104, 2005
50. Vignery A: Osteoclasts and giant cells: Macrophage- macrophage fusion mechanism. Int J Exp Pathol 81: 291-304, 2000
51. Martinez FO, Sica A, Mantovani A, Locati M: Macrophage activation and polarization. Front Biosci 13: 453-461, 2008
52. Mosser DM, Edwards JP: Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8: 958-969, 2008
53. Nishida M, Okumura Y, Fujimoto S, Shiraishi I, Itoi T, Hamaoka K: Adoptive transfer of macrophages ameliorates renal fibrosis in mice. Biochem Biophys Res Commun 332: 11-16, 2005
54. Schaier M, Vorwalder S, Sommerer C, Dikow R, Hug F, Gross ML, Waldherr R, Zeier M: Role of FTY720 on M1 and M2 macrophages, lymphocytes, and chemokines in 5/6 nephrectomized rats. Am J Physiol Renal Physiol 297: F769-F780, 2009
55. Denning TL, Wang YC, Patel SR, Williams IR, Pulendran B: Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17-producing T cell responses. Nat Immunol 8: 1086-1094, 2007
56. Bedoret D, Wallemacq H, Marichal T, Desmet C, Quesada Calvo F, Henry E, Closset R, Dewals B, Thielen C, Gustin P, de Leval L, Van Rooijen N, Le Moine A, Vanderplasschen A, Cataldo D, Drion PV, Moser M, Lekeux P, Bureau F: Lung interstitial macrophages alter dendritic cell functions to prevent airway allergy in mice. J Clin Invest 119: 3723-3738, 2009
57. Wang Y, Wang YP, Zheng G, Lee VW, Ouyang L, Chang DH, Mahajan D, Coombs J, Wang YM, Alexander SI, Harris DC: Ex vivo programmed macrophages ameliorate experimental chronic inflammatory renal disease. Kidney Int 72: 290-299, 2007
58. Zheng D, Wang Y, Lee VW, Cao Q, Zheng G, Sun Y, Harris DC: Regulatory macrophages protect against renal injury in murine streptozotocin-induced diabetes. Nephrology (Carlton) 13: A138, 2008
59. Lee VWS, Zheng D, Wang Y, Alexander SI, Harris DCH: Alternatively- activated macrophages, but not regulatory T lymphocytes, ameliorate renal injury in diabetic endothelial nitric oxide synthase knockout mice. Presented in abstract form at the annual meeting of the American Society of Nephrology; October 27 through November 1, 2009; San Diego, CA
60. Cao Q, Wang Y, Zheng D, Sun Y, Wang Y, Lee VW, Alexander SI, Harris DC: IL-10/ TGFb-modified macrophages induce regulatory T cells and protect against murine Adriamycin nephrosis. J Am Soc Nephrol 21: 939-942, 2010
61. Cao Q, Wang Y, Zheng D, Wang Y, Lee VM, Zheng G, Alexander SI, Harris DC: Discrete functions of protective macrophages determine their relative therapeutic effecacy in chronic kidney disease. Nephrology (Carlton) 14: A16, 2009
62. Cao Q, Zheng D, Sun Y, Wang Y, Lee VW, Zheng G, Alexander SI, Harris DC: Impaired alternative activated macrophages from bone marrow in treatment of CKD: Associations with their proliferation in inflamed kidney. Presented in abstract form at the annual meeting of the American Society of Nephrology; October 27 through November 1, 2009; San Diego, CA
63. Schebesch C, Kodelja V, Muller C, Hakij N, Bisson S, Orfanos CE, Goerdt S: Alternatively activated macrophages actively inhibit proliferation of peripheral blood lymphocytes and CD4+ T cells in vitro. Immunology 92: 478-486, 1997
64. Sica A, Bronte V: Altered macrophage differentiation and immune dysfunction in tumor development. J Clin Invest 117: 1155-1166, 2007
65. Lumeng CN, Bodzin JL, Saltiel AR: Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 117: 175-184, 2007
66. Eddy AA: Progression in chronic kidney disease. Adv Chronic Kidney Dis 12: 353-365, 2005